Metabolic pathways and immunometabolism in rare kidney diseases

Annals of the Rheumatic Diseases

Volumn 77, Issue 8, 2018, Pages 1227-1234

  Grayson, Peter C ^a,b   Eddy, Sean ^c,d   Taroni, Jaclyn N ^b,e   Lightfoot, Yaíma L ^a   Mariani, Laura ^c,d   Parikh, Hemang ^b,f   Lindenmeyer, Maja T ^g   Ju, Wenjun ^c,d   Greene, Casey S ^b,e   Godfrey, Brad ^c,d   Cohen, Clemens D ^g   Krischer, Jeffrey ^b,f   Kretzler, Matthias ^c,d   Merkel, Peter A ^b,h  

^a NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

^b Vasculitis Clinical Research Consortium   (United States)

^c UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^d Nephrotic Syndrome Study Network Consortia   (United States)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

^f UNIVERSITY OF SOUTH FLORIDA   (United States)

^g UNIVERSITY OF MUNICH   (Germany)

^h UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

granulomatosis with polyangiitis; lupus nephritis; systemic vasculitis

Indexed keywords

CD68 ANTIGEN; ENOLASE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; GLUCOSE TRANSPORTER; HEXOKINASE; MESSENGER RNA; PHOSPHOGLUCONATE DEHYDROGENASE; TRANSKETOLASE; TUMOR NECROSIS FACTOR; CYTOKINE; ISOENZYME; TRANSCRIPTOME;

ADULT; ANCA ASSOCIATED VASCULITIS; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVATION; ENZYME REGULATION; FEMALE; G6PD GENE; GENE; GENE EXPRESSION PROFILING; GENETIC ASSOCIATION; GLOMERULUS FILTRATION RATE; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; NEPHROTIC SYNDROME; PENTOSE PHOSPHATE CYCLE; PGD GENE; PGLS GENE; PRIORITY JOURNAL; RPE GENE; RPIA GENE; STEADY STATE; SYSTEMIC LUPUS ERYTHEMATOSUS; TALDO1 GENE; TKT GENE; AGED; BIOPSY; BIOSYNTHESIS; GENE EXPRESSION REGULATION; GENETICS; GLOMERULONEPHRITIS; GLOMERULUS; IMMUNOLOGY; KIDNEY TUBULE; METABOLISM; MIDDLE AGED; PATHOLOGY; YOUNG ADULT;

ADULT; AGED; ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS; BIOPSY; CYTOKINES; FEMALE; GENE EXPRESSION REGULATION; GLOMERULONEPHRITIS; HUMANS; ISOENZYMES; KIDNEY GLOMERULUS; KIDNEY TUBULES; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; METABOLIC NETWORKS AND PATHWAYS; MIDDLE AGED; NEPHROTIC SYNDROME; PENTOSE PHOSPHATE PATHWAY; RNA, MESSENGER; TRANSCRIPTOME; YOUNG ADULT;

EID: 85048999264     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2017-212935     Document Type: Article

References (38)

1. O'Neill LA, Kishton RJ, Rathmell J. A guide to immunometabolism for immunologists. Nat Rev Immunol 2016;16:553-65.
2. Tannahill GM, Curtis AM, Adamik J, et al. Succinate is an inflammatory signal that induces IL-1β through HIF-1α. Nature 2013;496:238-42.
3. Galvan-Pena S, O'Neill LA. Metabolic reprograming in macrophage polarization. Front Immunol 2014;5:420.
4. Moon JS, Hisata S, Park MA, et al. mTOR C1-Induced HK1-Dependent Glycolysis Regulates NLRP3 Inflammasome Activation. Cell Rep 2015;12:102-15.
5. Haschemi A, Kosma P, Gille L, et al. The sedoheptulose kinase CARKL directs macrophage polarization through control of glucose metabolism. Cell Metab 2012;15:813-26.
6. Jha AK, Huang SC, Sergushichev A, et al. Network integration of parallel metabolic and transcriptional data reveals metabolic modules that regulate macrophage polarization. Immunity 2015;42:419-30.
7. O'Neill LA, Pearce EJ. Immunometabolism governs dendritic cell and macrophage function. J Exp Med 2016;213:15-23.
8. Kim S, Hwang J, Xuan J, et al. Global metabolite profiling of synovial fluid for the specific diagnosis of rheumatoid arthritis from other inflammatory arthritis. PLoS One 2014;9:e97501.
9. Jiang M, Chen T, Feng H, et al. Serum metabolic signatures of four types of human arthritis. J Proteome Res 2013;12:3769-79.
10. Weyand CM, Goronzy JJ. Immunometabolism in early and late stages of rheumatoid arthritis. Nat Rev Rheumatol 2017;13:291-301.
11. Yang Z, Fujii H, Mohan SV, et al. Phosphofructokinase deficiency impairs ATP generation, autophagy, and redox balance in rheumatoid arthritis T cells. J Exp Med 2013;210:2119-34.
12. Morel L. Immunometabolism in systemic lupus erythematosus. Nat Rev Rheumatol 2017;13:280-90.
13. Fernandez DR, Telarico T, Bonilla E, et al. Activation of mammalian target of rapamycin controls the loss of TCRzeta in lupus T cells through HRES-1/Rab4-regulated lysosomal degradation. J Immunol 2009;182:2063-73.
14. Perl A, Hanczko R, Lai ZW, et al. Comprehensive metabolome analyses reveal N-acetylcysteine-responsive accumulation of kynurenine in systemic lupus erythematosus: implications for activation of the mechanistic target of rapamycin. Metabolomics 2015;11:1157-74.
15. Yin Y, Choi SC, Xu Z, et al. Normalization of CD4+ T cell metabolism reverses lupus. Sci Transl Med 2015;7:274ra18.
16. Shved N, Warsow G, Eichinger F, et al. Transcriptome-based network analysis reveals renal cell type-specific dysregulation of hypoxia-associated transcripts. Sci Rep 2017;7:8576.
17. Lindenmeyer MT, Kretzler M, Boucherot A, et al. Interstitial vascular rarefaction and reduced VEGF-A expression in human diabetic nephropathy. J Am Soc Nephrol 2007;18:1765-76.
18. Levey AS, Coresh J, Greene T, et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 2006;145:247-54.
19. Ju W, Greene CS, Eichinger F, et al. Defining cell-type specificity at the transcriptional level in human disease. Genome Res 2013;23:1862-73.
20. Gadegbeku CA, Gipson DS, Holzman LB, et al. Design of the Nephrotic Syndrome Study Network (NEPTUNE) to evaluate primary glomerular nephropathy by a multidisciplinary approach. Kidney Int 2013;83:749-56.
21. Mariani LH, Martini S, Barisoni L, et al. Interstitial fibrosis scored on whole-slide digital imaging of kidney biopsies is a predictor of outcome in proteinuric glomerulopathies. Nephrol Dial Transplant 2018;33:310-8.
22. Cohen CD, Frach K, Schlondorff D, et al. Quantitative gene expression analysis in renal biopsies: a novel protocol for a high-throughput multicenter application. Kidney Int 2002;61:133-40.
23. Dai M, Wang P, Boyd AD, et al. Evolving gene/transcript definitions significantly alter the interpretation of GeneChip data. Nucleic Acids Res 2005;33:e175.
24. Johnson WE, Li C, Rabinovic A. Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics 2007;8:118-27.
25. Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A 2001;98:5116-21.
26. Schmid H, Boucherot A, Yasuda Y, et al. Modular activation of nuclear factorkappaB transcriptional programs in human diabetic nephropathy. Diabetes 2006;55:2993-3003.
27. Caspi R, Billington R, Ferrer L, et al. The MetaCyc database of metabolic pathways and enzymes and the BioCyc collection of pathway/genome databases. Nucleic Acids Res 2016;44:D471-D480.
28. Bolen CR, Uduman M, Kleinstein SH. Cell subset prediction for blood genomic studies. BMC Bioinformatics 2011;12:258.
29. Newman AM, Liu CL, Green MR, et al. Robust enumeration of cell subsets from tissue expression profiles. Nat Methods 2015;12:453-7.
30. Renal tubule cells. http://nano.princeton.edu/standard/view/renal-tubule/
31. Eddy S, Mariani L, Martini S, et al. An Integrative genomics approach to predict patients with TNF activation in progressive nephrotic syndrome. Kidney Precision meeting abstract. http://www.niddk. nih.gov/ news/ events-calendar/ Documents/ abstract.pdf.
32. Berden AE, Ferrario F, Hagen EC, et al. Histopathologic classification of ANCAassociated glomerulonephritis. J Am Soc Nephrol 2010;21:1628-36.
33. Marin-Hernandez A, Gallardo-Perez JC, Ralph SJ, et al. HIF-1 alpha modulates energy metabolism in cancer cells by inducing over-expression of specific glycolytic isoforms. Mini Rev Med Chem 2009;9:1084-101.
34. Atsumi T, Chesney J, Metz C, et al. High expression of inducible 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (iPFK-2; PFKFB3) in human cancers. Cancer Res 2002;62:5881-7.
35. Simpson IA, Dwyer D, Malide D, et al. The facilitative glucose transporter GLUT3: 20 years of distinction. Am J Physiol Endocrinol Metab 2008;295:E242-E253.
36. Federzoni EA, Humbert M, Torbett BE, et al. CEBPA-dependent HK3 and KLF5 expression in primary AML and during AML differentiation. Sci Rep 2014;4:4261.
37. Cheadle C, Berger AE, Andrade F, et al. Transcription of proteinase 3 and related myelopoiesis genes in peripheral blood mononuclear cells of patients with active Wegener's granulomatosis. Arthritis Rheum 2010;62:1744-54.
38. Sas KM, Kayampilly P, Byun J, et al. Tissue-specific metabolic reprogramming drives nutrient flux in diabetic complications. JCI Insight 2016;1:e86976.